IL22 and myeloid sarcoma: Increased levels of Th17 cytokines (IL‐17A, IL‐17F and IL‐22) and decreased levels of Treg cytokines (IL‐10 and TGFB) were described to play a role in MS pathogenesis, including immune cell recruitment and exacerbation of CNS inflammation.